Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Cost-effective implementation of a custom MALDI-TOF library for the identification of South Australian Nocardia isolates.

Forero Morales MP, Hopprich R, Wise R, Shephard L, Weldhagen GF.

Pathology. 2018 Dec;50(7):753-757. doi: 10.1016/j.pathol.2018.08.006. Epub 2018 Oct 25.

PMID:
30482608
2.

Mycobacterial inactivation protein extraction protocol for matrix-assisted laser desorption ionization time-of-flight characterization of clinical isolates.

Morales MPF, Lim CK, Shephard L, Weldhagen GF.

Int J Mycobacteriol. 2018 Jul-Sep;7(3):217-221. doi: 10.4103/ijmy.ijmy_104_18.

3.

Rare Human Infection with Pacific Broad Tapeworm Adenocephalus pacificus, Australia.

Moore CV, Thompson RC, Jabbar A, Williams J, Rasiah K, Pallant L, Koehler AP, Graham C, Weldhagen GF.

Emerg Infect Dis. 2016 Aug;22(8):1510-2. doi: 10.3201/eid2208.160156. No abstract available.

4.

Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14.

Knight DR, Giglio S, Huntington PG, Korman TM, Kotsanas D, Moore CV, Paterson DL, Prendergast L, Huber CA, Robson J, Waring L, Wehrhahn MC, Weldhagen GF, Wilson RM, Riley TV.

J Antimicrob Chemother. 2015 Nov;70(11):2992-9. doi: 10.1093/jac/dkv220. Epub 2015 Jul 28.

PMID:
26221017
5.

First human case of fatal Halicephalobus gingivalis meningoencephalitis in Australia.

Lim CK, Crawford A, Moore CV, Gasser RB, Nelson R, Koehler AV, Bradbury RS, Speare R, Dhatrak D, Weldhagen GF.

J Clin Microbiol. 2015 May;53(5):1768-74. doi: 10.1128/JCM.00032-15. Epub 2015 Feb 18.

6.

Ceftriaxone treatment failure in cephalosporin-susceptible Escherichia coli bacteraemia.

Papanicolas LE, Bell JM, Weldhagen GF, Bastian I.

Int J Antimicrob Agents. 2013 Mar;41(3):298-9. doi: 10.1016/j.ijantimicag.2012.11.008. Epub 2013 Jan 9. No abstract available.

PMID:
23312600
7.

Random amplified polymorphic DNA typing of clinical and environmental Aeromonas hydrophila strains from Limpopo province, South Africa.

Ramalivhana JN, Obi CL, Samie A, Labuschagne C, Weldhagen GF.

J Health Popul Nutr. 2010 Feb;28(1):1-6.

8.

Emergence of class 1 integron-associated GES-5 and GES-5-like extended-spectrum beta-lactamases in clinical isolates of Pseudomonas aeruginosa in South Africa.

Labuschagne Cde J, Weldhagen GF, Ehlers MM, Dove MG.

Int J Antimicrob Agents. 2008 Jun;31(6):527-30. doi: 10.1016/j.ijantimicag.2008.01.020. Epub 2008 Apr 23.

PMID:
18436436
9.

Salmonella typhi central nervous system infection.

Meyer L, Ehlers MM, Dove MG, Weldhagen GF.

S Afr Med J. 2007 Mar;97(3):154, 156. No abstract available.

10.

Genetic stability of class 1 integron-borne blaGES-type genes under short-term in vitro antibiotic stress.

Weldhagen GF.

Int J Antimicrob Agents. 2006 Nov;28(5):481-3. Epub 2006 Sep 26. No abstract available.

PMID:
17000087
13.
14.

Integrons and beta-lactamases--a novel perspective on resistance.

Weldhagen GF.

Int J Antimicrob Agents. 2004 Jun;23(6):556-62. Review.

PMID:
15194125
15.

Candida famata central nervous system infection.

Prinsloo B, Weldhagen GF, Blaine RW.

S Afr Med J. 2003 Aug;93(8):601-2. No abstract available.

PMID:
14531119
16.

Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact.

Weldhagen GF, Poirel L, Nordmann P.

Antimicrob Agents Chemother. 2003 Aug;47(8):2385-92. Review. No abstract available.

17.

A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum beta-lactamase GES-2 in South Africa.

Poirel L, Weldhagen GF, De Champs C, Nordmann P.

J Antimicrob Chemother. 2002 Mar;49(3):561-5.

PMID:
11864961
18.

GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem.

Poirel L, Weldhagen GF, Naas T, De Champs C, Dove MG, Nordmann P.

Antimicrob Agents Chemother. 2001 Sep;45(9):2598-603.

Supplemental Content

Loading ...
Support Center